Skip to main content
Fachgebiete
Automobil + Motoren Bauwesen + Immobilien Business IT + Informatik Elektrotechnik + Elektronik Energie + Nachhaltigkeit Finance + Banking Management + Führung Marketing + Vertrieb Maschinenbau + Werkstoffe Versicherung + Risiko
DE
EN
Bücher
Zeitschriften
Themenseiten
Organisationspsychologie Projektmanagement Marketing Smart Manufacturing
Weitere Formate
Podcasts Webinare Technik Webinare Wirtschaft Kongresse Veranstaltungskalender Awards
Jetzt Einzelzugang starten
Zugang für Unternehmen
Referenzkunden
SLX-Digitalkonferenz: Zukunftswerkstatt 2024

Mehr Umsatz mit Top-Kontakten

Am 7. Mai erfahren Sie, wie Vertriebsteams Leadgenerierung, Leadnurturing und Leadstrategien effizient steuern können.
Erweiterte Suche
Anmelden
nach oben
Erschienen in:
Data-Driven and Minimal-Type Compartmental Insulin-Glucose Models: Theory and Applications Kapitel lesen Erstes Kapitel lesen

2014 | OriginalPaper | Buchkapitel

Simulation Models for In-Silico Evaluation of Closed-Loop Insulin Delivery Systems in Type 1 Diabetes

verfasst von : Malgorzata E. Wilinska, Roman Hovorka

Erschienen in: Data-driven Modeling for Diabetes

Verlag: Springer Berlin Heidelberg

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

This chapter presents simulation models created to support the development of closed-loop insulin delivery systems in type 1 diabetes. Such models, also known as ‘virtual patient’ models, represent an input-output relationship between insulin delivery and other external inputs such as meals or exercise, and the resulting glucose response. It is argued that these simulation models are an essential prerequisite for an accelerated development of the artificial pancreas systems in various populations of type 1 diabetes ranging from children to adults and pregnancies. The present review provides a general introduction to the models of glucose regulation in type 1 diabetes and then proceeds to discussing the individual submodels of glucose kinetics and insulin action, subcutaneous insulin kinetics, subcutaneous glucose kinetics, glucose absorption from the gut, and the exercise effect on the glucose kinetics. Finally, several important virtual-patient models used for in silico testing of glucose controllers are reviewed.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Jetzt informieren
Vorheriges Kapitel Pitfalls in Model Identification: Examples from Glucose-Insulin Modelling
Nächstes Kapitel Simple Parameters Describing Gut Absorption and Lipid Dynamics in Relation to Glucose Metabolism During a Routine Oral Glucose Test
Literatur
1.
Bolie VW (1960) Coefficients of normal blood glucose regulation. J Clin Invest 39:783–788
2.
Steele R (1959) Influences of glucose loading and injected insulin on hepatic glucose output. Ann NY Acad Sci 82:420–430CrossRef
3.
Cobelli C, Bergman RN (1981) Carbohydrate Metabolism: quantitative physiology and mathematical modelling. Wiley, New York
4.
Carson ER, Cobelli C, Finkelstein L (1983) The mathematical modeling of metabolic and endocrine systems, 1st edn. Wiley, New York
5.
Lehmann ED, Deutsch T, Roudsari AV, Carson ER, Sonksen PH (1993) Validation of a metabolic prototype to assist in the treatment of insulin-dependent diabetes mellitus. Med Inform 18:83–101CrossRef
6.
Rutscher A, Salzsieder E, Fischer U (1994) KADIS—model-aided education in type-i diabetes. Comput Methods Programs Biomed 41:205–215CrossRef
7.
Andreassen S, Benn JJ, Hovorka R, Olesen KG, Carson ER (1994) A probabilistic approach to glucose prediction and insulin dose adjustment: description of metabolic model and pilot evaluation study. Comput Methods Programs Biomed 41:153–165CrossRef
8.
Eddy DM, Schlessinger L (2003) Archimedes—a trial-validated model of diabetes. Diab Care 26:3093–3101CrossRef
9.
Bergman RN, Phillips LS, Cobelli C (1981) Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and β-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68:1456–1467CrossRef
10.
DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214–E223
11.
Zheng Y, Kreuwel HTC, Young DL, Shoda LKM, Ramanujan S, Gadkar KG et al (2007) The virtual NOD mouse—applying predictive biosimulation to research in type 1 diabetes. How do we best employ animal models for type 1 diabetes and multiple sclerosis? 1103: 45–62
12.
Klonoff DC (2005) Continuous glucose monitoring—roadmap for 21st century diabetes therapy. Diab Care 28:1231–1239CrossRef
13.
Hovorka R (2006) Continuous glucose monitoring and closed-loop systems. Diabet Med 23:1–12CrossRef
14.
Hovorka R (2008) The future of continuous glucose monitoring: closed loop. Curr Diab Rev 4:269–279CrossRef
15.
Hovorka R, Wilinska ME, Chassin LJ, Dunger DB (2006) Roadmap to the artificial pancreas. Diab Res Clin Pract 74:S178–S182CrossRef
16.
Cobelli C, Renard E, Kovatchev B (2011) Artificial pancreas: past, present, future. Diabetes 60:2672–2682CrossRef
17.
Kumareswaran K, Evans ML, Hovorka R (2012) Closed-loop insulin delivery: towards improved diabetes care. Discov Med 13:159–170
18.
Mari A (2002) Mathematical modeling in glucose metabolism and insulin secretion. Curr Opin Clin Nutr Metab Care 5:495–501CrossRef
19.
Parker RS, Doyle FJ (2001) Control-relevant modeling in drug delivery. Adv Drug Deliv Rev 48:211–228CrossRef
20.
Makroglou A, Li J, Kuang Y (2006) Mathematical models and software tools for the glucose-insulin regulatory system and diabetes: an overview. Appl Numer Math 56:559–573CrossRefMATHMathSciNet
21.
Parker RS, Doyle FJ III, Peppas NA (2001) The intravenous route to blood glucose control. IEEE Eng Med Biol Mag 20:65–73
22.
Bellazzi R, Nucci G, Cobelli C (2001) The subcutaneous route to insulin-dependent diabetes therapy. IEEE Eng Med Biol Mag 20:54–64CrossRef
23.
Steil GM, Panteleon AE, Rebrin K (2004) Closed-loop insulin delivery-the path to physiological glucose control. Adv Drug Deliv Rev 56:125–144CrossRef
24.
Tiran J, Galle KR, Porte D (1975) Simulation-model of extracellular glucose distribution in human body. Ann Biomed Eng 3:34–46CrossRef
25.
Sorensen JT (1985) A physiologic model of glucose metabolism in man and its use to design and assess improved insulin therapies for diabetes. Massachusetts Institute of Technology Ph.D, Cambridge
26.
Hovorka R, Shojaee-Moradie F, Carroll PV, Chassin LJ, Gowrie IJ, Jackson NC et al (2002) Partitioning glucose distribution/transport, disposal, and endogenous production during IVGTT. Am J Physiol 282:E992–E1007
27.
Tiran J, Avruch LI, Albisser AM (1979) A circulation and organs model for insulin dynamics. Am J Physiol 237:E331–E339
28.
Guyton JR, Foster RO, Soeldner JS, Tan MH, Kahn CB, Koncz L et al (1978) A model of glucose-insulin homeostasis in man that incorporates the heterogeneous fast pool theory of pancreatic insulin release. Diabetes 27:1027–1042CrossRef
29.
Cramp DG, Carson ER (1981) The dynamics of short-term blood glucose regulation. In: Cobelli C, Bergman RN (eds) Carbohydrate metabolism: quantitative physiology and mathematical modelling. Wiley, Chichester, pp 349–367
30.
Cobelli C, Federspil G, Pacini G, Salvan A, Scandellari C (1982) An integrated mathematical model of the dynamics of blood glucose and its hormonal control. Math Biosc 58:27–60CrossRefMATH
31.
Ackerman E, Gatewood LC, Rosevear JW, Molnar GD (1965) Model studies of blood-glucose regulation. Bull Math Biophys 27:21–37
32.
Yipintsoi T, Gatewood LC, Ckerman E, Spivak PL, Molnar GD, Rosevear JW et al (1973) Mathematical analysis of blood glucose and plasma insulin responses to insulin infusion in healthy and diabetic subjects. Comput Biol Med 3:71–78CrossRef
33.
Rewers M, Zaccaro D, D’Agostino R, Haffner S, Saad MF, Selby JV et al (2004) Insulin sensitivity, insulinemia, and coronary artery disease: the insulin resistance atherosclerosis study. Diab Care 27:781–787CrossRef
34.
Hong J, Gui MH, Gu WQ, Zhang YF, Xu M, Chi ZN et al (2008) Differences in insulin resistance and pancreatic B-cell function in obese subjects with isolated impaired glucose tolerance and isolated impaired fasting glucose. Diabetic Med 25:73–79CrossRef
35.
Bloem CJ, Chang AM (2008) Short-term exercise improves beta-cell function and insulin resistance in older people with impaired glucose tolerance. J Clin Endocrinol Metab 93:387–392CrossRef
36.
Salinari S, Bertuzzi A, Asnaghi S, Guidone C, Manco M, Mingrone G (2009) First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery. Diab Care 32:375–380CrossRef
37.
Kovatchev BP, Breton M, Man CD, Cobelli C (2009) In Silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes. J Diab Sci Technol 3:44–55CrossRef
38.
Regittnig W, Trajanoski Z, Leis HJ, Ellmerer M, Wutte A, Sendlhofer G et al (1999) Plasma and interstitial glucose dynamics after intravenous glucose injection—evaluation of the single-compartment glucose distribution assumption in the minimal models. Diabetes 48:1070–1081CrossRef
39.
Finegood DT, Tzur D (1996) Reduced glucose effectiveness associated with reduced insulin release—an artifact of the minimal-model method. Am J Physiol 34:E485–E495
40.
Quon MJ, Cochran C, Taylor SI, Eastman RC (1994) Non-insulin-mediated glucose disappearance in subjects with IDDM—discordance between experimental results and minimal model analysis. Diabetes 43:890–896CrossRef
41.
Weber KM, Martin IK, Best JD, Alford FP, Boston RC (1989) Alternative method for minimal model analysis of intravenous glucose tolerance data. Am J Physiol 256:E524–E535
42.
Cobelli C, Pacini G, Toffolo G, Sacca L (1986) Estimation of insulin sensitivity and glucose clearance from minimal model: new insights from labeled IVGTT. Am J Physiol 250:E591–E598
43.
Avogaro A, Bristow JD, Bier DM, Cobelli C, Toffolo G (1989) Stable-label intravenous glucose tolerance test minimal model. Diabetes 38:1048–1055CrossRef
44.
Caumo A, Cobelli C (1993) Hepatic glucose production during the labeled IVGTT: estimation by deconvolution with a new minimal model. Am J Physiol 264:E829–E841
45.
Vicini P, Caumo A, Cobelli C (1997) The hot IVGTT two-compartment minimal model: indexes of glucose effectiveness and insulin sensitivity. Am J Physiol 273:E1024–E1032
46.
Cobelli C, Caumo A, Omenetto M (1999) Minimal model S-G overestimation and S-I underestimation: improved accuracy by a Bayesian two-compartment model. Am J Physiol 277:E481–E488
47.
Ferrannini E, Smith JD, Cobelli C, Toffolo G, Pilo A, DeFronzo RA (1985) Effect of insulin on the distribution and disposition of glucose in man. J Clin Invest 76:357–364CrossRef
48.
Berger M, Cuppers HJ, Hegner H, Jorgens V, Berchtold P (1982) Absorption kinetics and biologic effects of subcutaneously injected insulin preparations. Diab Care 5:77–91CrossRef
49.
Binder C, Lauritzen T, Faber O, Pramming S (1984) Insulin pharmacokinetics. Diabetes 7:188–199
50.
Owens DR, Jones MK, Birtwell AJ, Burge CT, Jones IR, Heyburn PJ et al (1984) Pharmacokinetics of subcutaneously administered human, porcine and bovine neutral soluble insulin to normal man. Horm Metab Res 16(Suppl 1):195–199
51.
Kang S, Brange J, Burch A, Volund A, Owens DR (1991) Absorption kinetics and action profiles of subcutaneously administered insulin analogues (AspB9GluB27, AspB10, AspB28) in healthy subjects. Diab Care 14:1057–1065CrossRef
52.
Nucci G, Cobelli C (2000) Models of subcutaneous insulin kinetics. A critical review. Comput Methods Programs Biomed 62:249–257CrossRef
53.
Kobayashi T, Sawano S, Itoh T, Kosaka K, Hirayama H, Kasuya Y (1983) The pharmacokinetics of insulin after continuous subcutaneous infusion or bolus subcutaneous injection in diabetic patients. Diabetes 32:331–336CrossRef
54.
Kraegen EW, Chisholm DJ (1984) Insulin responses to varying profiles of subcutaneous insulin infusion: kinetic modelling studies. Diabetologia 26:208–213CrossRef
55.
Puckett WR (1995) LIGHTFOOT M: a model for multiple subcutaneous insulin injections developed from individual diabetic patient data. Am J Physiol 269:E1115–E1124
56.
Shimoda S, Nishida K, Sakakida M, Konno Y, Ichinose K, Uehara M et al (1997) Closed-loop subcutaneous insulin infusion algorithm with a short-acting insulin analog for long-term clinical application of a wearable artificial endocrine pancreas. Front Med Biol Eng 8:197–211
57.
Berger M, Rodbard D (1989) Computer-simulation of plasma-insulin and glucose dynamics after subcutaneous insulin injection. Diab Care 12:725–736CrossRef
58.
Mosekilde E, Jensen KS, Binder C, Pramming S, Thorsteinsson B (1989) Modeling absorption kinetics of subcutaneous injected soluble insulin. J Pharmacokinet Biopharm 17:67–87CrossRef
59.
Trajanoski Z, Wach P, Kotanko P, Ott A, Skraba F (1993) Pharmacokinetic model for the absorption of subcutaneously injected soluble insulin and monomeric insulin analogs. Biomed Tech 38:224–231CrossRef
60.
Hovorka R, Powrie JK, Smith GD, Sonksen PH, Carson ER, Jones RH (1993) Five-compartment model of insulin kinetics and its use to investigate action of chloroquine in NIDDM. Am J Physiol 265:E162–E175
61.
Wilinska ME, Chassin LJ, Schaller HC, Schaupp L, Pieber TR, Hovorka R (2005) Insulin kinetics in type-1 diabetes: continuous and bolus delivery of rapid acting insulin. IEEE Trans Biomed Eng 52:3–12CrossRef
62.
Bolinder J, Ungerstedt U, Arner P (1993) Long-term continuous glucose monitoring with microdialysis in ambulatory insulin-dependent diabetic-patients. Lancet 342:1080–1085CrossRef
63.
Trajanoski Z, Brunner GA, Schaupp L, Ellmerer M, Wach P, Pieber TR et al (1997) Open-flow microperfusion of subcutaneous adipose tissue for on- line continuous ex vivo measurement of glucose concentration. Diab Care 20:1114–1121CrossRef
64.
Schaupp L, Brunner GA, Schaller H, Bodelenz M, Wutte A, Wach P et al (2001) Glucose monitoring in the adipose tissue of type 1 diabetic patients using open-flow microperfusion and microdialysis. Diabetologia 44:A46CrossRef
65.
Pfeiffer EF, Meyerhoff C, Bischof F, Keck FS, Kerner W (1993) On line continuous monitoring of subcutaneous tissue glucose is feasible by combining portable glucosensor with microdialysis. Horm Metab Res 25:121–124CrossRef
66.
Sternberg F, Meyerhoff C, Mennel FJ, Mayer H, Bischof F, Pfeiffer EF (1996) Does fall in tissue glucose precede fall in blood glucose? Diabetologia 39:609–612CrossRef
67.
Freeland AC, Bonnecaze RT (1999) Inference of blood glucose concentrations from subcutaneous glucose concentrations: applications to glucose biosensors. Ann Biomed Eng 27:525–537CrossRef
68.
Schmidtke DW, Freeland AC, Heller A, Bonnecaze RT (1998) Measurement and modeling of the transient difference between blood and subcutaneous glucose concentrations in the rat after injection of insulin. Proc Natl Acad Sci USA 95:294–299CrossRef
69.
Wilinska ME, Bodenlenz M, Chassin LJ, Schaller HC, Schaupp LA, Pieber TR et al (2004) Interstitial glucose kinetics in subjects with type 1 diabetes under physiologic conditions. Metab Clin Exp 53:1484–1491CrossRef
70.
Worthington DR (1997) Minimal model of food absorption in the gut. Med Inform (Lond) 22:35–45CrossRef
71.
Arleth T, Andreassen S, Orsini-Federici M, Timi A, Massi-Benedetti M (2000) A model of glucose absorption from mixed meals. Model Control Biomed Syst 2000:307–312
72.
Dalla Man C, Rizza RA, Cobelli C (2006) Mixed meal simulation model of glucose-insulin system. In: 2006 28th annual international conference of the IEEE engineering in medicine and biology society, Vols 1–15. 3769–3772
73.
Goodyear LJ, Hirshman MF, Horton ES (1991) Exercise-induced translocation of skeletal-muscle glucose transporters. Am J Physiol 261:E795–E799
74.
Thorell A, Hirshman MF, Nygren J, Jorfeldt L, Wojtaszewski JFP, Dufresne SD et al (1999) Exercise and insulin cause GLUT-4 translocation in human skeletal muscle. Am J Physiol Endocrinol Metab 277:E733–E741
75.
Ren JM, Semenkovich CF, Gulve EA, Gao JP, Holloszy JO (1994) Exercise induces rapid increases in Glut4 expression, glucose-transport capacity, and insulin-stimulated glycogen-storage in muscle. J Biol Chem 269:14396–14401
76.
DCCT Research Group (1991) Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med 90:450–459CrossRef
77.
Fischer U, Salzsieder E, Stowhas H, Rutscher A (1994) Model-based prevention in iddm of exercise-induced hypoglycemia. Diabetes 43:A218
78.
Derouich M, Boutayeb A (2002) The effect of physical exercise on the dynamics of glucose and insulin. J Biomech 35:911–917CrossRef
79.
Hernandez-Ordonez M, Campos-Delgado DU (2008) An extension to the compartmental model of type 1 diabetic patients to reproduce exercise periods with glycogen depletion and replenishment. J Biomech 41:744–752CrossRef
80.
Kim J, Saidel GM, Cabrera ME (2007) Multi-scale computational model of fuel homeostasis during exercise: effect of hormonal control. Ann Biomed Eng 35:69–90CrossRef
81.
Breton MD (2008) Physical activity-the major unaccounted impediment to closed loop control. J Diab Sci Technol 2:169–174CrossRef
82.
Bergman RN, Ider YZ, Bowden CR, Cobelli C (1979) Quantitative estimation of insulin sensitivity. Am J Physiol 236:E667–E677
83.
Guelfi KJ, Jones TW, Fournier PA (2005) The decline in blood glucose levels is less with intermittent high-intensity compared with moderate exercise in individuals with type 1 diabetes. Diab Care 28:1289–1294CrossRef
84.
Chassin LJ, Wilinska ME, Hovorka R (2007) Intense exercise in type 1 diabetes: exploring the role of continuous glucose monitoring. J Diab Sci Technol 1:164–167CrossRef
85.
Shichiri M, Kawamori R, Yamasaki Y, Hakui N, Abe H (1982) Wearable artificial endocrine pancreas with needle-type glucose sensor. Lancet 2:1129–1131CrossRef
86.
Vering T, Beyer U, Both M, Heiniger H, Hutzli I, Kalt L et al (2003) Minimally invasive control loop system for SC-SC control on patients with type 1 diabetes. In: Third annual diabetes technology meeting. San Francisco, p A21
87.
Galley P, Wagner R, Buck H, Weinert S, Bousamra S, Long J (2004) Use of subcutaneous glucose measurements to drive real-time algorithm-directed insulin infusion recommendations. Diab Technol Ther 6:245–246
88.
Hovorka R, Chassin LJ, Wilinska ME, Canonico V, Akwi JA, Federici MO et al (2004) Closing the loop: the adicol experience. Diab Technol Ther 6:307–318CrossRef
89.
Chassin LJ, Wilinska ME, Hovorka R (2004) Evaluation of glucose controllers in virtual environment: methodology and sample application. Artif Intell Med 32:171–181CrossRef
90.
Hovorka R, Canonico V, Chassin LJ, Haueter U, Massi-Benedetti M, Orsini FM et al (2004) Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. Physiol Meas 25:905–920CrossRef
91.
Wilinska ME, Chassin LJ, Acerini CL, Allen JM, Dunger DB, Hovorka R (2010) Simulation environment to evaluate closed-loop insulin delivery systems in type 1 diabetes. J Diab Sci Technol 4:132–144CrossRef
92.
Hovorka R, Allen JM, Elleri D, Chassin LJ, Harris J, Xing D et al (2010) Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. Lancet 375:743–751CrossRef
93.
Elleri D, Allen JM, Kumareswaran K, Leelarathna L, Nodale M, Caldwell K et al (2013) Closed-loop basal insulin delivery over 36 h in adolescents with type 1 diabetes: randomized clinical trial. Diab Care 36:838–844CrossRef
94.
Hovorka R, Kumareswaran K, Harris J, Allen JM, Elleri D, Xing D et al (2011) Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies. Br Med J 342:d1855CrossRef
95.
Murphy HR, Elleri D, Allen JM, Harris J, Simmons D, Rayman G et al (2011) Closed-loop insulin delivery during pregnancy complicated by type 1 diabetes. Diab Care 34:406–411CrossRef
96.
Bode B, Gross K, Rikalo N, Schwartz S, Wahl T, Page C et al (2004) Alarms based on real-time sensor glucose values alert patients to hypo-and hyperglycemia: the guardian continuous monitoring system. Diab Technol Ther 6:105–113CrossRef
97.
Kanderian S, Saad MF, Rebrin K, Steil GM (2006) Modeling glucose profiles obtained using closed loop insulin delivery—implications for controller cptimization. Diabetes 55[Suppl 1]:A98
98.
Kanderian SS, Weinzimer SA, Steil GM (2012) The identifiable virtual patient model: comparison of simulation and clinical closed-loop study results. J Diab Sci Technol 6:371–379CrossRef
99.
Dalla Man C, Rizza RA, Cobelli C (2007) Meal simulation model of the glucose-insulin system. IEEE Trans Biomed Eng 54:1740–1749
100.
Basu R, Di Camillo B, Toffolo G, Basu A, Shah P, Vella A et al (2003) Use of a novel triple-tracer approach to assess postprandial glucose metabolism. Am J Physiol Endocrinol Metab 284:E55–E69
101.
Vicini P, Sparacino G, Caumo A, Cobelli C (1997) Estimation of endogenous glucose production after a glucose perturbation by nonparametric stochastic deconvolution. Comput Methods Programs Biomed 52:147–156CrossRef
102.
Ferrannini E, Cobelli C (1987) The kinetics of insulin in man. I. General aspects. Diab Metab Rev 3:335–363
103.
Parker RS, Doyle FJ, III, Peppas NA (1999) A model-based algorithm for blood glucose control in type I diabetic patients. IEEE Trans Biomed Eng 46:148–157
104.
Parker RS, Doyle FJ, Ward JH, Peppas NA (2000) Robust H-infinity glucose control in diabetes using a physiological model. AIChE J 46:2537–2549CrossRef
105.
Fabietti PG, Canonico V, Federici MO, Benedetti MM, Sarti E (2006) Control oriented model of insulin and glucose dynamics in type 1 diabetics. Med Biol Eng Comput 44:69–78CrossRef
Metadaten
Titel
Simulation Models for In-Silico Evaluation of Closed-Loop Insulin Delivery Systems in Type 1 Diabetes
verfasst von
Malgorzata E. Wilinska
Roman Hovorka
Copyright-Jahr
2014
Verlag
Springer Berlin Heidelberg
Buch
Data-driven Modeling for Diabetes

Print ISBN: 978-3-642-54463-7

Electronic ISBN: 978-3-642-54464-4

Copyright-Jahr: 2014

DOI
https://doi.org/10.1007/978-3-642-54464-4_6

Neuer Inhalt

    Bildnachweise